Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2018

View Archived Issues

The locus of alcohol's reward

GBM cells spread their message beyond death

FDA clears of IND application for OC-01 as treatment of dry eye disease

Kangpu initiates phase I study of KPG-121 for metastatic CRPC

Inovio reports phase I results for INO-4700 in MERS

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas

Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement

Melinta Therapeutics describes leads from the pyrrolocytosine class of antibiotics

Kymab to test KY-1044 in combination with atezolizumab in clinical trials

Researchers present preclinical data for [11C]NOP-46

European Commission approves Xeljanz for active psoriatic arthritis

Arsanis discontinues phase II study of ASN-100

Ziopharm initiates phase I trial of Ad-RTS-hIL-12 plus veledimex with nivolumab in recurrent GBM

INDIGO-1 study of gemcabene in severe hypertriglyceridemia meets primary endpoint

Trevena completes first-in-human study of TRV-250 for treatment of acute migraine

ProQR initiates phase I/II WINGS trial of QR-313

Phase III MEDALIST study of luspatercept meets primary and key secondary endpoints

EMA committee recommends approval of Cablivi for aTTP

New MAP4K1 inhibitors identified at Ariad Pharmaceuticals

FUJIFILM, Nagoya City University patent flycosylated chlorin e6 derivatives

Aclaris reports promising interim data from phase II trial of ATI-501 in severe alopecia areata

Preliminary in vivo pharmacokinetics for [125I]p93 reported

Novartis to spin off Alcon eye care devices business

Japan Tobacco and Torii Pharmaceutical discontinue development of JTS-661

G1T38 demonstrates safety and early evidence of antitumor activity in breast cancer

First-in-human results presented from VANCE study of ChAdOx1-MVA 5T4 vaccine

Galapagos reports topline results for GLPG-2737, updates triple combination plans in cystic fibrosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...